Markus F.
- Country
- Germany
- Department
- Gynecology and obstetric
Research Overview
- Phase III Randomized Trial of Platinum-Based Chemotherapy with Paclitaxel, Bevacizumab, and Atezolizumab in Metastatic, Persistent, or Recurrent Cervical Carcinoma
- Phase III Randomized Double-Blind Placebo-Controlled Trial of Letrozole Maintenance Therapy in Epithelial Ovarian Cancer Post-Surgery and Chemotherapy
Data & Insights
Has run more than one trial at 5 of 79 partner sites.
Specializations
Gynecologic Oncology
The investigator specializes in treating advanced gynecological cancers, with particular emphasis on epithelial ovarian cancer and cervical carcinoma. Their research encompasses innovative therapeutic approaches in gynecologic malignancies.
- Advanced Ovarian Cancer Management
- Cervical Cancer Treatment Strategies
- Maintenance Therapy Protocols
Their expertise extends to treating metastatic and recurrent forms of gynecologic cancers.
Therapeutic Approaches
The investigator focuses on combination treatment strategies including targeted therapies and immunotherapy. Their work involves evaluating novel therapeutic combinations incorporating biological agents.
- Endocrine Therapy
- Immunotherapy Applications
- Combination Treatment Protocols
Their research explores the integration of various therapeutic modalities in gynecologic cancer treatment.
Clinical Outcomes
The investigator's research focuses on evaluating treatment efficacy through key clinical endpoints including progression-free survival and overall survival in gynecologic cancers.
- Survival Outcomes Assessment
- Disease Progression Evaluation
- Treatment Response Monitoring
Their work contributes to understanding long-term outcomes in gynecologic cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.